2024年12月9日 · Adstiladrin (nadofaragene firadenovec-vncg) is a gene therapy used to treat high-risk Bacillus CalmetteGuérin (BCG)-unresponsive non-muscle invasive bladder cancer. Includes Adstiladrin side effects, interactions and indications.

Nadofaragene firadenovec, sold under the brand name Adstiladrin, is a gene therapy for the treatment of bladder cancer. [1][3][4] It is a non-replicating (cannot multiply in human cells) adenoviral vector-based gene therapy. [3]

ADSTILADRIN® is the first and only FDA-approved gene therapy for treating adult patients with high-risk BCG-unresponsive NMIBC. See Important Safety Info.

ADSTILADRIN is a non-replicating adenoviral vector-based gene therapy indicated for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in …

For the treatment of High-grade, Bacillus Calmette-Guerin (BCG) unresponsive non-muscle invasive bladder cancer.

5 天之前 · ADSTILADRIN® (nadofaragene firadenovec) is the first FDA-approved gene therapy for a urological cancer, offering new hope for NMIBC patients. This therapy is designed specifically for high-risk NMIBC that no longer responds to …

ADSTILADRIN is a non-replicating adenoviral vector-based gene therapy indicated for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive...

ADSTILADRIN is a one-of-a-kind gene therapy that fights high-risk NMIBC directly in the bladder. ADSTILADRIN uses a viral vector to carry a gene called interferon alpha 2B (IFNα2b) into the cells of the bladder lining

2024年11月4日 · ADSTILADRIN is a non-replicating adenoviral vector-based gene therapy indicated for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors. (1)

ADSTILADRIN is a non-replicating adenoviral vector-based gene therapy indicated for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in …